These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19389436

  • 21. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP.
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [Abstract] [Full Text] [Related]

  • 22. RNA interference inhibitors of hepatitis B virus.
    McCaffrey AP.
    Ann N Y Acad Sci; 2009 Sep; 1175():15-23. PubMed ID: 19796073
    [Abstract] [Full Text] [Related]

  • 23. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
    Pellish RS, Nasir A, Ramratnam B, Moss SF.
    Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
    [Abstract] [Full Text] [Related]

  • 24. Bioinformatic approaches to siRNA selection and optimization.
    Muhonen P, Holthofer H.
    Methods Mol Biol; 2010 May; 623():93-107. PubMed ID: 20217546
    [Abstract] [Full Text] [Related]

  • 25. State-of-the-art modified RNAi compounds for therapeutics.
    Carstea ED, Hough S, Wiederholt K, Welch PJ.
    IDrugs; 2005 Aug; 8(8):642-7. PubMed ID: 16044372
    [Abstract] [Full Text] [Related]

  • 26. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ, ter Brake O, Berkhout B.
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [Abstract] [Full Text] [Related]

  • 27. A systematic analysis of the effect of target RNA structure on RNA interference.
    Westerhout EM, Berkhout B.
    Nucleic Acids Res; 2007 Jun; 35(13):4322-30. PubMed ID: 17576691
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J, Fisher KA, Darcy R, Cryan JF, O'Driscoll C.
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [Abstract] [Full Text] [Related]

  • 29. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD, Huang L.
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [Abstract] [Full Text] [Related]

  • 30. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
    Reischl D, Zimmer A.
    Nanomedicine; 2009 Mar; 5(1):8-20. PubMed ID: 18640078
    [Abstract] [Full Text] [Related]

  • 31. siRNA delivery systems for cancer treatment.
    Oh YK, Park TG.
    Adv Drug Deliv Rev; 2009 Aug 10; 61(10):850-62. PubMed ID: 19422869
    [Abstract] [Full Text] [Related]

  • 32. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
    Mantei A, Rutz S, Janke M, Kirchhoff D, Jung U, Patzel V, Vogel U, Rudel T, Andreou I, Weber M, Scheffold A.
    Eur J Immunol; 2008 Sep 10; 38(9):2616-25. PubMed ID: 18792414
    [Abstract] [Full Text] [Related]

  • 33. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J, Bartos M.
    Cas Lek Cesk; 2008 Sep 10; 147(12):607-15. PubMed ID: 19235485
    [Abstract] [Full Text] [Related]

  • 34. RNA interference as an anticancer therapy: a patent perspective.
    Dykxhoorn DM.
    Expert Opin Ther Pat; 2009 Apr 10; 19(4):475-91. PubMed ID: 19441927
    [Abstract] [Full Text] [Related]

  • 35. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK, Hajeri PB.
    Drug Discov Today; 2009 Sep 10; 14(17-18):859-65. PubMed ID: 19540929
    [Abstract] [Full Text] [Related]

  • 36. Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis.
    Hadj-Slimane R, Lepelletier Y, Lopez N, Garbay C, Raynaud F.
    Biochimie; 2007 Oct 10; 89(10):1234-44. PubMed ID: 17707573
    [Abstract] [Full Text] [Related]

  • 37. Synthetic vs. natural/biodegradable polymers for delivery of shRNA-based cancer therapies.
    Vorhies JS, Nemunaitis JJ.
    Methods Mol Biol; 2009 Oct 10; 480():11-29. PubMed ID: 19085121
    [Abstract] [Full Text] [Related]

  • 38. Advances in the development of siRNA-based therapeutics for cancer.
    Shen Y.
    IDrugs; 2008 Aug 10; 11(8):572-8. PubMed ID: 18683092
    [Abstract] [Full Text] [Related]

  • 39. Multiple shRNA expressions in a single plasmid vector improve RNAi against the XPA gene.
    Nagao A, Zhao X, Takegami T, Nakagawa H, Matsui S, Matsunaga T, Ishigaki Y.
    Biochem Biophys Res Commun; 2008 May 30; 370(2):301-5. PubMed ID: 18367095
    [Abstract] [Full Text] [Related]

  • 40. Hydrodynamic delivery of siRNA in a mouse model of sepsis.
    Wesche-Soldato DE, Lomas-Neira J, Perl M, Chung CS, Ayala A.
    Methods Mol Biol; 2008 May 30; 442():67-73. PubMed ID: 18369778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.